Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis >

Nemus Bioscience, Inc. (NMUS)

Add NMUS Price Alert      Hide Sticky   Hide Intro
Moderator: Paulieme
Search This Board: 
Last Post: 11/21/2017 11:05:56 PM - Followers: 109 - Board type: Free - Posts Today: 0


 NEMUS BIOSCIENCE™ provides pharmaceutical research and development services focused on discovering, developing, and commercializing new chemical entities from a class of chemically diverse compounds. We develop novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company Website:

Filings and disclosure with Level 2 quotes:


(949) 396-0330


Nemus Bioscience (NMUS) Presentation (47 minutes):

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016:


Major press releases:

A Sit Down With Nemus Bioscience; Cannabinoids In Focus Feb. 1, 2017 11:06 AM ET Nemus Bioscience, Inc. (NMUS)  

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -

Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy

Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)


Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model


Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.

NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 

CANNAINVESTOR Magazine Top 20 Cannabis Stocks 


NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 


NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 


NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 


Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 


NMUS Security Details

Share Structure - as of Feb 1, 2017

Authorized Shares: 236,000,000
Outstanding Shares: 
      - Restricted  13,494,621
    - Unrestricted   8,943,542

           - Float   5,005,713 a/o Mar 23, 2016 
   Par Value 0.001

Transfer Agent: Clear Trust, LLC

Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NMUS News: Quarterly Report (10-q) 11/14/2017 05:06:39 PM
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 11/14/2017 04:53:12 PM
NMUS News: Small Company Offering and Sale of Securities Without Registration (d) 11/14/2017 03:30:01 PM
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 11/02/2017 06:14:41 AM
NMUS News: Current Report Filing (8-k) 11/02/2017 06:14:33 AM
#2975   Vinpat says 'Doug Ingram is involved day-to-day' AntonChigurh 11/21/17 11:05:56 PM
#2974   Having said that, Elsohly developed the transmucosal patch cjarmstrong 11/17/17 12:33:57 PM
#2973   I said old news, but that I didn't cjarmstrong 11/16/17 09:56:05 AM
#2972   It was Insys and No one hear new AntonChigurh 11/15/17 10:07:01 PM
#2971   Old news. I posted that there was a cjarmstrong 11/15/17 06:51:23 PM
#2970 JANUARY 16, 2009 AntonChigurh 11/15/17 05:32:56 PM
#2969   The simplest explanation is most often the correct one. dary4321 11/14/17 04:19:42 PM
#2968   You don't get involved with Bad guys like AntonChigurh 11/14/17 12:05:02 PM
#2967   That is precisely what I did June 12th marctabar 11/14/17 05:20:32 AM
#2966   What does your good friend Vinpat have to cjarmstrong 11/14/17 12:38:21 AM
#2965   I think he probably has AntonChigurh 11/13/17 11:14:36 PM
#2964   So why are you guys holding this company dary4321 11/13/17 10:42:52 PM
#2963   Why didn't you report them to a regulatory cjarmstrong 11/13/17 10:19:23 PM
#2962   regarding Schneider, I worked for them as the marctabar 11/13/17 10:08:33 PM
#2961   Is "fake news" something people call other people? cjarmstrong 11/13/17 09:53:56 PM
#2960   Financial guarantee: Schneider leaves its customers in the AntonChigurh 11/13/17 07:18:44 PM
#2959   What? cjarmstrong 11/13/17 04:58:48 PM
#2958   Did you just call me Fake News, CJ? AntonChigurh 11/13/17 04:51:57 PM
#2957   The officer of the shell is irrelevant, he's cjarmstrong 11/13/17 04:50:31 PM
#2956   I am just Really excited for it, that's AntonChigurh 11/13/17 02:01:37 PM
#2955   Are you suggesting that they're late on their Vinpat 11/13/17 01:41:36 PM
#2954   Maybe Schneider can pay Nemus 10 million Ubiquicoin AntonChigurh 11/13/17 12:55:27 PM
#2953   However, we can reasonably argue that he (John marctabar 11/13/17 10:41:16 AM
#2952   Where is the 8K filing for the last AntonChigurh 11/10/17 05:31:49 PM
#2951   LOL Closewatcher 11/09/17 06:23:03 PM
#2950   That's fine but what does that have to Vinpat 11/09/17 04:48:04 PM
#2949   This is going to be fun GLTFA AntonChigurh 11/09/17 04:43:21 PM
#2948   He seems like a sharp guy and everyone Vinpat 11/09/17 04:39:21 PM
#2947   You can find it on the internet or AntonChigurh 11/09/17 04:39:02 PM
#2946   Not alleging anything my friend. Just informing this AntonChigurh 11/09/17 04:37:00 PM
#2945   Not his first weird post. I take it cjarmstrong 11/09/17 04:28:26 PM
#2943   I have no idea what you're alleging. If Vinpat 11/09/17 04:08:05 PM
#2942   Thanks counselor. I wonder why it's being taken Vinpat 11/09/17 03:58:18 PM
#2941   My point is Vinpat, you have been around AntonChigurh 11/09/17 03:56:09 PM
#2940   John Severson, who has lots of money, is AntonChigurh 11/09/17 03:54:52 PM
#2939   It looks like the local guy might be Vinpat 11/09/17 01:22:59 PM
#2938   Nemus took over a shell company and Mendez Vinpat 11/09/17 12:19:21 PM
#2937   Arbitration sounds good. On a contingent fee basis Jdanger 2 11/09/17 11:40:43 AM
#2936   Good morning! AntonChigurh 11/09/17 11:02:50 AM
#2935   Sure wish Murphy would do something to rally Jdanger 2 11/08/17 03:57:05 PM
#2934   I never said current. I don't want to AntonChigurh 11/08/17 02:26:59 PM
#2933   Berecz could make her salary anywhere and Murphy Vinpat 11/08/17 02:16:00 PM
#2932   When people say 'management hasn't enriched themselves' They AntonChigurh 11/08/17 01:18:49 PM
#2931   I won't argue that as it relates to Vinpat 11/08/17 01:16:34 PM
#2930   Problems are rough at this stage. I'm on Closewatcher 11/08/17 01:13:36 PM
#2929   They have not proven themselves to be effective a surfer 11/08/17 01:00:43 PM
#2928   if you want to be critical of execution Vinpat 11/08/17 12:07:14 PM
#2927   If they can fix thier problem this will Djdjdjdj 11/08/17 11:02:54 AM
#2926   What do you mean 'no one' has enriched AntonChigurh 11/08/17 12:05:48 AM
#2925   Great post! a surfer 11/07/17 09:04:52 PM